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S U M M A R Y
Most cases of strongyloidiasis associated with solid organ transplantation have been due to the
reactivation of a latent infection in the recipient as a result of the immunosuppressive therapy; however,
donor-derived infections are becoming increasingly frequent. The case of a patient who nearly died of a
Strongyloides stercoralis hyperinfection after receiving simultaneous kidney/pancreas transplants is
described herein. No speciﬁc parasitological tests were performed pre-transplantation, despite the fact
that both the recipient and the donor originated from endemic areas. Serological analysis of the donor’s
serum performed retrospectively revealed the origin of the infection, which if it had been done
beforehand would have prevented the serious complications. Current practice guidelines need to be
updated to incorporate immunological and molecular techniques for the rapid screening of Strongyloides
prior to transplantation, and empirical treatment with ivermectin should be applied systematically
when there is the slightest risk of infection in the donor or recipient.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Strongyloides stercoralis is an intestinal nematode parasite that
affects about 30–100 million people around the world, but is
mainly found in tropical and subtropical areas where hygiene
standards and sanitary conditions are deﬁcient. However, there are
small endemic foci of the disease in countries with a temperate
climate.1 In immunocompetent individuals, this infection is often
asymptomatic or has a mild symptomatology, characterized by
high eosinophilia, pulmonary symptoms, dermatological manifes-
tations, and intestinal symptoms. However, there are some risk
factors, such as co-infection with HIV or human T-cell lympho-
tropic virus (HTLV1), corticosteroid treatment, and induced
immunosuppression, which can lead to a hyperinfection syndrome
(HS) or disseminated strongyloidiasis (DS), the latter having a fatal
course in most cases.2
The case of an intestinal hyperinfection of S. stercoralis
associated with simultaneous kidney/pancreas transplantation is* Corresponding author.
E-mail address: maria.trelis@uv.es (M. Trelis).
http://dx.doi.org/10.1016/j.ijid.2016.08.014
1201-9712/ 2016 The Author(s). Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).described herein. The recipient presented acute duodenitis and a
profound nutritional decline after the solid organ transplantation.
This represents a case of donor-derived strongyloidiasis. The donor
originated from an endemic area, Bolivia, and was diagnosed with
two important parasitic diseases – trypanosomiasis and toxoplas-
mosis – before donation. However, in the case of Strongyloides, no
parasitological tests or empirical treatment, as recommended in
the national guidelines, were performed.
2. Case report
The case patient was a 37-year-old male from Segorbe, Valencia
(Spain), whose medical history included type 1 diabetes mellitus for
32 years. The patient was the recipient of a kidney and pancreas
from a single donor (who had also donated his other kidney and his
liver), without rejection and with a favourable course. Post-
transplantation, the following drug scheme was followed: (1)
trimethoprim/sulfamethoxazole (400 mg/80 mg/day for 6 months),
ganciclovir (900 mg/day for 90 days), and ﬂuconazole (200 mg/day
for 60 days), to prevent opportunistic parasitic infections,
cytomegalovirus (CMV), and fungi, respectively; (2) basiliximabciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
A. Galiano et al. / International Journal of Infectious Diseases 51 (2016) 19–2120for the induction of immunosuppressive therapy; and (3) predni-
sone, tacrolimus, and mycophenolate mofetil as immunosuppres-
sive maintenance.
Two months after surgery, he attended the hospital accident and
emergency unit complaining of profuse diarrhoea, weakness, and
abdominal pain. At the time of admission, he presented no fever,
mucocutaneous dryness, hypotension, or malnutrition. A complete
blood test conﬁrmed anaemia (haemoglobin of 10.6 g/dl), with a
white cell count of 9.26  109/l and eosinophil count of 0.12  109/l.
His abdomen was soft and depressible; the kidney graft on the left
iliac fossa was palpable, without pain or signs of peritoneal
irritation.
Laboratory tests were performed for the diagnosis of possible
infectious agents responsible for the diarrhoea. The patient was
positive for Clostridium difﬁcile toxin, which masked the parasitosis,
and was thus started on metronidazole treatment (500 mg/8 h for
7 days). Further testing for Clostridium 1 week later was negative,
but the episodes of diarrhoea continued. Oesophago-gastroduode-
noscopy revealed an oedematous and ulcerated mucosa of the
duodenal bulb, as well as necrotic tissue. The mucosal condition
extended to the second duodenal portion. A biopsy of the ﬁrst
duodenal portion revealed an intense immune response caused by
the presence of the parasite S. stercoralis (Figure 1). Stool samples
were sent to the laboratory for microscopic observation and culture,
resulting in the ﬁnding of rhabditiform larvae. The patient was
started on treatment with ivermectin (200 g/kg/day for 7 days),
which was repeated 15 days thereafter and prolonged for another
5 days to ensure eradication of the parasite. New stool samples were
analyzed and were eventually negative.Figure 1. Histology of the duodenal biopsy taken during the ﬁrst oesophago-
gastroduodenoscopy (haematoxylin and eosin): (A) multiple Strongyloides
stercoralis larvae in the duodenum mucosa (arrows); (B) magniﬁed image
showing transverse sections of the larvae.Due to the severity of this patient’s protein–energy malnutrition,
parenteral nutrition was necessary. His general condition improved
progressively, and he recovered normal intestinal function.
The recipient was born in the region of La Safor (Spain). He
reported having travelled to the Dominican Republic, an area
considered endemic for Strongyloides, 10 years ago. Nonetheless,
he had not presented eosinophilia either before or immediately
after the intervention, and had also never presented symptoms
consistent with parasitism.
The donor was a 34-year-old man from Bolivia. In the pre-
transplant blood tests he showed slight eosinophilia (2.5%), so
there were no clear signs of helminthiasis. Furthermore, the
recommended tests for Strongyloides (stool examination and
culture of larvae) were not performed before donation. However,
his test results were positive for Trypanosoma cruzi and Toxoplasma
gondii. His liver and the other kidney were transplanted into two
other recipients, who did not develop strongyloidiasis. Following
the diagnosis of HS in the recipient, the donor’s serum was
obtained from the biobank and analyzed by ELISA; the sample
showed a positive titre for anti-Strongyloides (IgG) antibodies,
thereby demonstrating the origin of the infection.
3. Discussion
The region of La Safor (Valencia) on the Spanish Mediterranean
Coast was once considered an endemic focus of strongyloidiasis.
Most documented cases involved people with jobs related to
manual rice cultivation, irrigation ditches or their maintenance.
Today, due to improvements in health infrastructure and the
mechanization of farming, it is considered that there is no
transmission of the disease in this region.3
In the case presented here, the patient originated from this part
of Spain, but neither he himself nor any other member of his family
had performed activities posing a risk. He reported having
travelled to the tropics, but had been careful to avoid possible
infection with parasites, including walking barefoot, and had not
presented any symptoms during or after this trip. Also, it should be
noted that this patient, because of his chronic illness, was subject
to strict medical control.
Donor-derived Strongyloides infections have been considered
rare, but an increasing number of cases have been reported
recently.4 In all of these, the donor was native to an endemic area,
as in the case presented here, in which the donor was from Bolivia.
Surprisingly, both the liver and the other kidney were also donated
to two different patients, and neither of them developed the
disease. However, a patch of duodenum tissue was transplanted
with the pancreas in the case presented here, thus it may be that
the parasites reached the recipient’s intestine through this tissue.
This case highlights the importance of updating the Spanish
Organizacio´n Nacional de Trasplantes (ONT) consensus document5
to include new more sensitive and rapid diagnostic tools for
strongyloidiasis and also emphasizes the need to assess the
potential risks not only in the donor but also in the recipient.
Screening serum by ELISA or faeces by real-time PCR may be very
useful for more rigorous control pre-transplantation, although
positive tests should not automatically lead to the exclusion of
potential donors or recipients. In certain situations, depending on
the risk factors present, empirical treatment with ivermectin is
recommended; thus, had the guidelines been followed, perhaps
the HS would have been avoided in this case.
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